Publié il y a 3 mois
Associate Process Engineer (12 month contract)
@ Aspect Biosystems
Vancouver, Colombie-Britannique
En bref
Aspect Biosystems is hiring an Associate Process Engineer on a 12-month contract to support aseptic manufacturing workflows for its bioprinted tissue therapeutics. The role covers fluidic systems, bioreactor scaling, process risk assessments, DOE work, technology transfer and regulatory content for CTA/IND filings. The posting asks for a BSc or MSc in a related field with 1-2+ years of cell therapy or biologics experience and GMP/GDP knowledge.
Salaire :
64 000 $–72 000 $ par année
Responsabilités :
- Support process design, execution and characterization of fluidic and bioreactor systems
- Participate in FMEA and PHA risk assessments
- Assist with DOE and define critical process parameters
- Support technology transfer and process qualification
- Assist with deviation investigations and root cause analysis
Résumé des exigences :
- BSc or MSc in chemical, bio or biomedical engineering or related life science
- 1-2+ years of biomanufacturing or cell therapy experience
- Hands-on process development and characterization experience
- GMP and GDP knowledge
- Analytical and communication skills
Outils et compétences
Source et dates
Site carrière / système de candidatures · greenhouse
- Date publiée par l’employeur
- 2026-08-21
- Première détection par notre source
- 2026-10-08
- Mise à jour du dossier source
- 2026-11-03
Ces dates décrivent le dossier source, pas une vérification en direct du recrutement. Consultez l’offre originale.
Détails du poste
| Niveau | Débutant |
| Domaine | Génie |
| Expérience | 1 an(s) et plus |
| Heures par semaine | 40 (estimé) |
| Milieu de travail | Laboratoire, Usine |
| Position | Assis et debout |
| Exigences physiques | physique faible · ordinateur modéré |
| Langues | English |
| Formation | Baccalauréat (exigé), Maîtrise (préféré) |
| Domaines d’études | Chemical Engineering, Bioengineering, Biomedical Engineering, Life Sciences |
Résumé et détails rédigés par l’IA à partir de l’offre; l’offre de l’employeur fait foi.
Aspect Biosystems
Profil d’entreprise sauvegardé
Renseignements historiques provenant d’un profil The Jobs API sauvegardé (champs LinkedIn/Crunchbase). Ils ne sont pas vérifiés en temps réel; les chiffres peuvent avoir changé. Les valeurs manquantes restent inconnues.
Developing Bioprinted Tissue Therapeutics to transform how we treat some of the most elusive diseases.
Description complète de l’entreprise
Aspect Biosystems is a biotechnology company pioneering the development of a novel category of cellular medicines designed to replace or restore biological function and deliver curative therapies for some of the most elusive diseases. Aspect is developing these bioengineered cellular medicines by applying its full-stack tissue therapeutic platform, which integrates proprietary AI-powered bioprinting technology, therapeutic cells, hypoimmune cell engineering, and advanced biomaterials. Aspect is advancing its therapeutic pipeline across multiple endocrine and metabolic diseases, including diabetes and rare endocrine disorders.
- Abonnés LinkedIn
- 28 490
- Personnes associées sur LinkedIn
- 145
- Bureaux déclarés
- 2131 Manitoba St, Vancouver, British Columbia V5Y 0N7, CA
- Catégories d’activité
- Health Care
- Biotechnology
- Life Science
- Artificial Intelligence (AI)
- 3D Printing
- Autres noms enregistrés
- Aspect Biosystems
- Spécialités
- bioprinting
- regenerative medicine
- therapeutic development
- and cell therapy
- Le profil indique une agence de recrutement
- Non
- Investissement total déclaré
- 252 846 526
La devise et la date d’observation ne sont pas fournies; ce n’est ni une valorisation actuelle ni une ronde de financement.
Aspect Biosystems is a biotechnology company pioneering the development of a novel category of cellular medicines designed to replace or restore biological function and deliver curative therapies for some of the most elusive diseases. Aspect is developing these bioengineered cellular medicines by applying its full-stack tissue therapeutic platform, which integrates proprietary AI-powered bioprinting technology…
| Champ | Valeur |
|---|---|
| Secteur | Biotechnology Research |
| Taille | 51-200 employees |
| Siège social | Vancouver, British Columbia |
| Type d’organisation | Privately Held |
| Fondée en | 2013 |
| Spécialités | bioprintingregenerative medicinetherapeutic developmentand cell therapy |
| Offres sur Jobsy | 4 |
| Voir la page |
We're looking for an enthusiastic Associate Process Engineer to join our dynamic and dedicated Process Development team. Reporting to the Head of Process Development, you will support the development of an aseptic manufacturing workflow for our bioprinted tissue therapeutics. You’ll be joining a company committed to developing regenerative medicines that deliver life-changing, functional cures for patients living with serious diseases. .
Responsibilities
- Assisting in the design, execution, and characterization of fluidic systems, bioreactor scaling strategies, and automated cell processing workflows (wash, concentrate, harvest) to support process robustness.
- Collaborating with Process Development, Bioengineering, Engineering, and Manufacturing team members to support technical integration of the cell therapy process into the final device platform, focusing on closed-system design and single-use technologies.
- Participating in process risk assessments (e.g., FMEA, PHA) for both the cell manufacturing process and its interaction with the medical device component.
- Utilizing mathematical models and Design of Experiments (DOE) methodologies under senior guidance to assist in defining critical process parameters (CPPs) and critical quality attributes (CQAs).
- Supporting technology transfer to Manufacturing, including assisting with process qualification and early phase clinical manufacturing as needed.
- Contributing to technical troubleshooting and assisting with out-of-specification investigation and root cause analysis during manufacturing deviations or process improvements.
- Supporting the execution of validation strategies for sterilization, biocompatibility, and extractables/leachables (E&L), and helping compile technical data for regulatory filings (CTA/IND).
- Identifying process improvement opportunities in current cell therapy manufacturing to help optimize yield, purity, and scalability.
- Continuously building your technical expertise while contributing to a culture of rigor and data-driven decision-making.
Qualifications
- Education + Experience: M.S. or BSc. in Chemical Engineering, Bioengineering, Biomedical Engineering, or a related life science field with 1-2+ years of relevant industry experience, in cell therapy, bioprocess development, or biologics manufacturing.
- Process Development & Characterization Experience: Hands-on background in the development, characterization, and optimization of biomanufacturing processes is required, preferably within cell therapy.
- Bioreactors: Experience with bioreactor systems and scaling strategies is desirable.
- GMP & GDP Knowledge: Knowledge of Good Manufacturing Practices (GMP) and Good Documentation Practices (GDP). Familiarity with regulatory requirements for cell therapy products (e.g., providing technical content for CTA/IND filings).
- Analytical and Communication Skills: Analytical, problem-solving, and data-driven decision-making skills. Excellent written and verbal communication skills, including the ability to present complex data and mentor junior team members.
The hiring range for this role is $64,000 - $72,000 CAD annually. Our ranges are based on market data. Offered salaries will be based on a combination of factors including, but not limited to, job-related knowledge, skills, education, and experience. For candidates who exceed role requirements, we are open to exploring above-range offers. Note that base salary is just one part of the overall compensation at Aspect. Members of the Aspect team also receive a comprehensive benefits package, and support for continuous learning and career progression.
Who We Are
Aspect Biosystems is a biotechnology company pioneering the development of a novel category of regenerative medicine designed to restore or supplement biological function and deliver curative therapies for some of the most elusive diseases. Aspect is developing these bioengineered cellular medicines by applying its full-stack tissue therapeutic platform, which integrates proprietary AI-powered bioprinting technology, therapeutic cells, hypoimmune cell engineering, and advanced biomaterials. Aspect is advancing its therapeutic pipeline across multiple endocrine and metabolic diseases, including diabetes and rare endocrine disorders. If you are committed to making a real impact and accelerating the development of life-changing therapies, we want to hear from you!
Curious about our current perks and benefits? Learn more here.
All aspects of employment - including the decision to hire, promote, discipline, or terminate - are based on merit, competence, performance, and business needs. We do not discriminate on the basis of race, color, religion, citizenship status, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, gender identity or expression, veteran status, political affiliation, or any other status protected under federal, state, provincial, or local law.
If you're interested in joining our team but don't see a job posting that matches your experience or background, we encourage you to submit a general application to be considered for future opportunities!
Journal
Visible seulement par vous. Conservé sur cet appareil, et dans votre compte une fois connecté.